The article compares Broadcom, a maker of networking chips and infrastructure software, with Dell Technologies, which sells servers, storage and PCs, as both benefit from AI demand. Broadcom posted revenue of about $63.9 billion in its fiscal year ended Nov. 2, 2025, up roughly 23.9%, with net income near $23.1 billion. Dell reported about $113.5 billion in revenue for the year ended Jan. 30, 2026, up roughly 18.8%, but its net margin was about 5.2%, versus Broadcom's close to 36.2%. The article flags Broadcom's customer concentration and Dell's competition and reliance on third-party manufacturers as key risks, and says Dell appears cheaper on forward P/E and price-to-sales.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
BroadcomDELLartificial intelligencesemiconductorsvaluation
Open a keyword to see other news on the same topic.
Related news
- AMD or Broadcom: If I Could Only Own 1 AI Chip Stock Through 2030, Here's My Pick
AMD and Broadcom have both benefited from the AI boom, with AMD shares up 421% and Broadcom up 285% over three years. In Q2, AMD's revenue rose 50% year over year to $11.5 billion, its data center segment reached $6.7 billion (up 107%), and non-GAAP EPS hit $1.66 (up 246%), with AMD projecting a $220 billion CPU opportunity and a $1.4 trillion AI accelerator opportunity by 2030. Broadcom's fiscal Q3 2026 revenue grew 86% to $29.6 billion, with AI semiconductor revenue up 221% to $16.7 billion, and it projects $115 billion in AI revenue for fiscal 2027 and $230 billion for fiscal 2028. The author gives a slight edge to Broadcom on valuation, at 19.4x forward earnings versus 39.5x for AMD, though AMD's EPS is growing faster. Broadcom's margins could decline as lower-margin AI chip sales take a larger share of its total revenue.
- Prediction: Broadcom Stock Could Crush the S&P 500 Through 2030
Broadcom's AI revenue is surging, with fiscal Q3 revenue of $29.59 billion (up 85.5% year over year) and AI semiconductor revenue of $16.70 billion, yet the stock is down 2.41% year to date while the S&P 500 is up 12.87%. Q3 gross margin fell 210 basis points sequentially to 75%, with Q4 guided to about 73% as memory-heavy XPUs dilute the mix, and customer concentration is another risk. The consensus target of $527.59 implies 57.4% upside from $335.18, while the article's base case is $410.50, or 22.47% upside. Reaching $700 requires a 108.8% gain, or about 38x forward EPS of $18.376; the article calls this a stretch but achievable if AI revenue meets the fiscal 2027 outlook and EPS clears $30 in fiscal 2028. The main risks are supply shortages of wafers, HBM, power or data center capacity, and a sharp pullback in hyperscaler spending.
- Has Buying Broadcom Stock's Dips Paid Off?
Broadcom (AVGO) shares fell 11.2% from their October 7, 2026 high to the October 20 close, with the steepest drop of 4.5% on October 16. Since 2010, Broadcom has had nine falls of over 20% within about six weeks; seven of them are more than a year old, and the shares were higher a year later in every case, with a median gain of 45%. Fiscal Q3 2026 revenue reached $29.6 billion, up 85.5%, with AI semiconductor revenue up 221% and operating margin at 54.3%. At the October 20 close, Broadcom traded at 41.6 times last twelve months' earnings, versus 23.0 for the S&P 500. Management expects fiscal Q4 2026 revenue of $34.8 billion, with results expected around December 9, 2026.
- Prediction: Broadcom Could Be the AI Winner After Nvidia
24/7 Wall St. rates Broadcom a buy with a 12-month price target of $425.56, which the article says implies 19.97% upside from $354.73. Broadcom has beaten EPS estimates for the ninth consecutive time, and fiscal Q3 revenue rose 85.5% year over year to $29.59B, with AI semiconductor revenue up 221% to $16.70B. Management guided AI semiconductor revenue to $21.70B next quarter and expects fiscal 2027 AI revenue of about $115 billion. Risks noted include having only six XPU customers, gross margin falling 210 basis points to 75%, and $59.6 billion of debt. The article puts NVIDIA near 46 times trailing earnings and AMD at about 224 times, and says Broadcom trades at a far lower multiple than either.
- Broadcom Stock Fell 4% as Chip Stocks Slid Days After a 10-Year VMware Deal. Here’s What Wall Street’s Targets Say
Broadcom fell 4.31% to $323.24 on October 22 as chip stocks slid on renewed worries about AI spending, three days after it signed NTT DOCOMO to a 10-year VMware agreement. Shares were about 33% below their June closing high, while the next-twelve-month EPS estimate rose 68% from $10.30 on February 1 to $17.34 on October 21, cutting the forward P/E from about 32 times to about 19 times. Infrastructure software, built mostly on VMware, added $8,752 million in fiscal Q3, up 29%, and earned about 77% segment operating margin in fiscal 2025 versus about 58% for semiconductors. The mean Street target of about $528 sits roughly 63% above the October 22 close, and 47 of 52 ratings are Buy or Outperform.
- Is Broadcom Stock Cheap Enough Yet?
Broadcom (AVGO) closed at $328.75 on October 16, 2026, 31.5% below its highest close of the past year, and shareholders lost 5.7% over twelve months while the S&P 500 returned 16.2%. The price-to-earnings multiple fell to 43.7 a year after 82.1 at the end of September 2025, as diluted EPS doubled from $3.92 to $7.83, yet it remains higher than at 19 of 35 earlier quarter ends since late 2017. The operating margin reached 48.5% over the twelve months to August 2, 2026, the highest at any quarter end since late 2016. AI semiconductor revenue was $16.7 billion in fiscal Q3 2026, 56% of total revenue, and management guided fiscal Q4 revenue to $34.8 billion, up 93%, while analysts expect about $35.6 billion. Management said supply is secured to roughly double AI revenue to about $115 billion in fiscal 2027, but land, power, and shell for data centers remain a major concern.
Related markets
Latest news
- Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying: the iShares Biotechnology ETF (IBB) is up 24% through October 23, after a 28% gain in 2025, with two dozen of its 233 holdings more than doubling year-to-date. Moderna leads with a 587% surge, though its stock fell 18% after a leak of positive cancer-vaccine trial data. Analysts attribute the rally to clinical trial results, M&A, and technologies such as mRNA, genomics and AI, with about a dozen novel biologics approved by the FDA in 2025 out of 46 approvals and roughly 66 novel drugs in the pipeline. The Moderna–Merck melanoma drug showed a 42% reduction in recurrence or death when combined with Keytruda in Phase 3 and is targeted for FDA submission and launch in 2027. Gene-sequencing firm Illumina more than doubled this year, and 10x Genomics rose more than 300%.
- SpaceX's "Super Intelligence" Segment Just Made the Stock a Must-Own
SpaceX's 'super intelligence' (SI) segment, formerly its AI business, generated $7.56 billion in Q3 revenue, up 830% from $813 million in 2025 and well above $2.56 billion in Q2. Most of the growth came from AI models, including subscription platforms, and infrastructure, which rose from $2.56 billion to $7.02 billion; X ad revenue grew from $454 million to $538 million. The segment's capital expenditures reached $16.4 billion in the quarter. The author views the stock as attractively priced at current levels if growth continues, but argues that such a pace may be hard to sustain, and the stock gave back its roughly 10% post-earnings gain by Thursday.
- Top Blockchains Continue to See Rapid Growth in AI Agent Payments. This Is the 1 Crypto You Need to Buy Right Now.
Chainalysis reported 138.5 million payments on Base using x402, a payment protocol built for AI agents, up from 58,800 transactions as of Q3 2025. Over 87% of x402 transactions were between $0.0001 and $0.10, sizes too small for traditional networks like Visa and Mastercard because of fees and chargeback risk. Solana ranks second in x402 volume, has overtaken Base in daily activity at several points this year, and launched batch settlement, which BlockRunAI says saves more than $20,000 a month in fees. However, TRM Labs counted $52.7 million across 198.9 million settlements since March 2025, with about $25.6 million plausible after removing suspicious activity, so agent payments are not yet driving much economic activity. Solana's stablecoin supply hit a record $17.3 billion in September, and the token trades about 64% below its January 2025 high of $293.
- 5 of the Fastest-Growing Stocks in the Market
The article ranks five fast-growing stocks by latest-quarter revenue growth: Nebius Group (NBIS), CoreWeave (CRWV), AppLovin (APP), Robinhood Markets (HOOD) and IREN (IREN), and examines what investors are paying for that growth. Nebius's second-quarter revenue jumped 454% year over year to $582.3 million, but at a price-to-sales ratio (P/S) of about 46, the highest of the five, its growth is largely funded by cash, customer prepayments and outside financing. CoreWeave's revenue rose 112.5% to around $2.6 billion, backed by a $104 billion revenue backlog, and it trades at 6.0 times sales, but $640 million in net interest expense means its growth relies heavily on debt. AppLovin grew revenue 53% to $1.9 billion, funded by its own profits and cash, at about 16 times sales, while Robinhood's revenue rose 32% to a record $1.3 billion at about 23 times sales, though trading activity can fall sharply when markets cool. IREN's total revenue fell 26.7% to $137.2 million as Bitcoin mining declined, while AI cloud revenue grew tenfold to $70.5 million at about 19 times sales; the article suggests AppLovin could be the safest option because its growth is funded by profits.
- Down Roughly 50% From Its Highs, Is Netflix Stock Finally a Buy?
Netflix (NFLX) shares have fallen roughly 50% from their all-time closing high of $133.91 on June 30, 2025, following the company's third-quarter report. Before the report, Netflix fired its chief content officer and announced its largest layoff since 2022, hiring former Disney executive Peter Rice as it struggled to produce U.S. blockbuster shows. In Q3, revenue rose 12% to $12.87 billion and adjusted EPS jumped 49% to $0.87, above the $0.82 analyst estimate compiled by LSEG. Netflix guided Q4 revenue to $13.4 billion but trimmed full-year revenue to $51.1 billion and cut its ad revenue forecast from $3 billion to $2.7 billion due to a slower ad rollout. The article argues that at a forward P/E of about 17 times 2027 estimates, the valuation now looks attractive.
- US objective is no more oil, nuclear issues, its total destruction of Iran: Foreign Affairs Expert Waiel Awwad
Foreign affairs expert Waiel Awwad told ANI that Washington's aim on Iran goes beyond nuclear talks to regime change and the disintegration of Iran, making Israel the dominant regional power. As crude oil reached USD 117 a barrel, the highest since April, Iran's Revolutionary Guard Corps claimed full control of the Strait of Hormuz, saying two supertankers carrying more than 4.5 million barrels struck naval mines on an unauthorised southern route. Iran's Chief of the General Staff Ali Abdollahi said Iran would not allow US military vessels into the Persian Gulf and questioned Trump's claims that Iran's nuclear facilities were destroyed. Separately, US Secretary of State Marco Rubio visited Reliance's Jamnagar refinery in India, where US Ambassador Sergio Gor said US LPG made up 67% of India's imports, up from below 10%.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.